Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia)
- 1 April 1990
- journal article
- Published by Elsevier BV in Cellular Immunology
- Vol. 126 (2), 278-289
- https://doi.org/10.1016/0008-8749(90)90321-h
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Modification of ribosomal RNA by ribosome-inactivating proteins from plantsNucleic Acids Research, 1988
- Heterogeneity of Natural Killer CellsAnnual Review of Immunology, 1984
- The cytotoxic and cytostatic effects of the bitter melon (Momordica charantia) on human lymphocytesToxicon, 1982
- Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cellsInternational Journal of Cancer, 1982
- Guanylate Cyclase Activity in Human Leukemic and Normal LymphocytesEnzyme, 1982
- Characteristics of human large granular lymphocytes and relationship to natural killer and K cellsThe Journal of Experimental Medicine, 1981
- Partial purification and characterization of a guanylate cyclase inhibitor with cytotoxic properties from the bitter melon (Momordica charantia)Biochemical and Biophysical Research Communications, 1980
- Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata)Biochemical and Biophysical Research Communications, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976